GE17-5478-06

Capto^™ L

Cytiva 17-5478-06, pack of 5 mL

• Codice UNSPSC: 23151817
• NACRES: NA.56

Proprietà

• ligand: recombinant protein L (E. coli), mammalian free
• Confezionamento: pack of 5 mL
• Produttore/marchio commerciale: Cytiva 17-5478-06
• Condizioni di stoccaggio: (20% Ehtanol)
• Matrice: rigid, highly cross-linked agarose
• Dimens. media delle particelle: 85 μm (d₅₀v is the median particle size of the cumulative volume distribution)
• working range: 2-10(pH interval where the medium can be operated without significant change in function.)
• Compatibilità: suitable for bioprocess medium
• Temperatura di conservazione: 2-8°C

Descrizione

Descrizione generale

Capto^™ L resin is designed for antibody fragment purification, when the fragment contains the kappa light chain.

Capto^™ L combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has a strong affinity to the variable region of antibody kappa light chains.

The high binding capacity and affinity to a broad range of antibody fragments makes this resin an excellent capture platform for antibody fragments containing kappa light chains. Common uses include domain antibody (dAb), scFv, and Fab purification.

Capto^™ L resin requires minimal optimization and produces high purity in one separation step, resulting in significant savings during process development. This resin is also advantageous in manufacturing, because high selectivity of affinity capture reduces the number of subsequent polishing steps.

Scale-up with this resin is straightforward and is further aided by a range of prepacked process development tools, such as PreDictor plates, PreDictor RoboColumn, and HiScreen^™ prepacked columns.

Caratteristiche e vantaggi

• Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and single-chain fragment variable (scFv) .
• High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
• Enables a platform approach to antibody fragment purification.
• Excellent productivity, process economy, and process design flexibility due to rigid matrix.
• Hydrophilic base matrix ensures low levels of non-specific binding and low levels of host cell-derived impurities in the elution pool.
• Fulfills industrial demands for security of supply, robust performance, and regulatory support.

Stoccaggio e stabilità

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Risultati analitici

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Note legali

Capto is a trademark of Cytiva

HiScreen is a trademark of Cytiva

Informazioni sulla sicurezza

• Pittogrammi: GHS02
• Avvertenze: Warning
• Indicazioni di pericolo: H226
• Consigli di prudenza: P280 - P210 - P241 - P235 - P303 + P361 + P353 - P501
• Codice della classe di stoccaggio: 3 - Flammable liquids